Season 1, Episode 12 (Season 1 Finale; Scalp Allergic Contact Dermatitis, PDL Laser Induced Hair Loss, Plaquenil Oral Pigmentation, Persistent Chemotherapy Induced Alopecia) Evidence Based Hair podcast

Evidence Based Hair « »

Season 1, Episode 12 (Season 1 Finale; Scalp Allergic Contact Dermatitis, PDL laser induced hair loss, Plaquenil Oral Pigmentation, Persistent Chemotherapy Induced Alopecia)

2y ago 1:08:49

Content provided by Dr Jeff Donovan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Jeff Donovan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Recording of the Evidence Based Hair Podcast for the April 25, 2022 issue.

STUDIES REFERENCED

ALLERGIC CONTACT DERMATITIS STUDIES

Feryel A et al (starts at 3:51). Unusual clinical presentation of allergic contact dermatitis to topical minoxidil. Contact Dermatitis. 2022 Mar 28

Pham et al (starts at 12:18). Allergic Contact Dermatitis of the Scalp Associated With Scalp Applied Products: A Systematic Review of Topical Allergens. Dermatitis. 2022 Mar 22.

PULSED DYE LASER AND HAIR LOSS IN INFANTILE HEMANGIOMAS

Yang et al (starts at 19:56). Risk factors of long-term alopecia after pulsed-dye laser treatment for infantile scalp hemangiomas: A retrospective study. J Dermatol. 2022 Apr 5.

Feldstein S et al. Can long-term alopecia occur after appropriate pulsed-dye laser therapy in hair-bearing sites? Pediatric dermatologists weigh in. Dermatol Surg. 2015 Mar;41(3):348-51.

ORAL PIGMENTATION FROM HYDROXYCHLOROQUINE

Silva PUJ et al (starts at 31:26). Oral pigmentation as an adverse effect of chloroquine and hydroxychloroquine use: A scoping review. Medicine (Baltimore). 2022 Mar 18;101(11):e29044.

PERMANENT CHEMOTHERAPY INDUCED ALOPECIA

Lyakhovitsky A et al (starts at 37:38). Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil. JAAD Case Rep. 2022 Feb 17;22:64-67.

Vano-Galvan S et al. Safety of low dose oral minoxidil for hair loss: A multicenter study of 1404 patients. JAAD 2021; 84: 1644-51.

Sanabria B et al. Adverse effects of low dose oral minoxidil for androgenetic alopecia in 435 patients. JAAD 2021; 84: 1175-78.

Kolla et al (starts at 54:24). Permanent chemotherapy-induced alopecia presenting with erosive pustular dermatosis-like retention hyperkeratosis. JAAD Case Rep. 2022 Jan 6;21:77-79.

Yin et al (starts at 58:25). Dermatologist Awareness of Scalp Cooling for Chemotherapy-induced Alopecia. J Am Acad Dermatol. 2022 Mar 9;S0190-9622(22)00386-3

58 episodes